autoICSI - Development of an AI-based fully automated Intracytoplasmic Sperm Injection system to improve fertility success

Myma Medical将与伯明翰大学和剑桥试管受精诊所合作，开发首个此类自动胞质内单精子注射(ICSI)系统，以改进生育治疗。“AutoICSI”将使用机器人、视觉识别和人工智能来最大限度地减少手动卵子操作和精子注射的不一致风险和潜在损害，帮助提高夫妇的成功率和可及性，提高诊所的盈利能力，并提高NHS临床调试小组(CCGs)的成本效益。

Myma Medical will collaborate with the University of Birmingham and Cambridge IVF fertility clinic to develop a first-of-its-kind automated Intracytoplasmic Sperm Injection (ICSI) system to improve fertility treatments."autoICSI" will use robotics, vision recognition and AI to minimise the risks of inconsistencies and damage potential of manual egg manipulation and sperm injection, helping improve success rates and accessibility for couples, profitability for clinics and cost-effectiveness for NHS Clinical Commissioning Groups(CCGs).